SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy

SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy

A 72-year-old immunocompromised man infected with severe acute respiratory syndrome coronavirus 2 received bamlanivimab monotherapy. Viral evolution was monitored in nasopharyngeal and blood samples by melting curve analysis of single-nucleotide polymorphisms and whole-genome sequencing. Rapid emer...

Full description

Bibliographic Details
Main Authors: Aurélie Truffot, Julien Andréani, Marion Le Maréchal, Alban Caporossi, Olivier Epaulard, Raphaele Germi, Pascal Poignard, Sylvie Larrat
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2021-10-01
Series:Emerging Infectious Diseases
Subjects:
coronavirus disease
COVID-19
severe acute respiratory syndrome coronavirus 2
SARS-CoV-2
coronaviruses
viruses
Online Access:https://wwwnc.cdc.gov/eid/article/27/10/21-1509_article

Internet

https://wwwnc.cdc.gov/eid/article/27/10/21-1509_article

Similar Items